Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Accumulated amortization of deferred leasing costs $ 36,416 $ 35,270
Common Shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common Shares of beneficial interest, shares authorized (in shares) 150,000,000 150,000,000
Common Shares of beneficial interest issued (in shares) 112,513,857 112,423,893
Common Shares of beneficial interest, shares outstanding (in shares) 112,513,857 112,423,893
Investing Receivables    
Investing receivable allowance for credit loss $ 2,937 $ 2,794